Literature DB >> 19996445

Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.

Douglas S Walsh1, Fredrick Eyase, David Onyango, Alfred Odindo, Walter Otieno, John N Waitumbi, Wallace D Bulimo, David C Schnabel, Wayne M Meyers, Françoise Portaels.   

Abstract

Mycobacterium ulcerans infection is an emerging disease that causes indolent, necrotizing skin lesions known as Buruli ulcer (BU) and occasional contiguous or metastatic bone lesions. Buruli ulcer is named after Buruli County in Uganda (east Africa), where an epidemic occurred in the 1960s. Today, BU is most common in central and west Africa. We describe clinical and molecular evidence for a case of BU in Kenya.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996445     DOI: 10.4269/ajtmh.2009.09-0313

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

Review 1.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

2.  Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs.

Authors:  Enid Owusu; Mercy J Newman; Amos Akumwena; Elizabeth Bannerman; Gerd Pluschke
Journal:  BMC Microbiol       Date:  2017-01-05       Impact factor: 3.605

3.  Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.

Authors:  Elizabeth Gyamfi; Charles A Narh; Charles Quaye; Adiza Abbass; Bartholomew Dzudzor; Lydia Mosi
Journal:  BMC Microbiol       Date:  2021-01-05       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.